We Have Moved Our Blog To TheFinanceProfessor.com

Scott Rothbort, "The Finance Professor", has moved the LakeView Asset Management Blog to the all new TheFinanceProfessor.com website.



TheFinanceProfessor.com is a unique and dynamic educational social networking site. So join us as we all Express Our Knowledge.

--- Exchange information and ideas in the Study Hall Forum

--- Interact with other members in our real time chat in The Trading Room

--- Help to build our Finance Wiki

--- Use the online Financial Calculator

--- Participate in an Investment Club.Join an existing club or start your won. If you are unaffiliated then The Finance Professor welcomes you to his own club

--- Upload your resume for thousands of potential employers to search

--- Read what The Finance Professor, Scott Rothbort has to say in his exclusive blog

--- Express Your Knowledge by submitting your own article for publication in the Call For Papers section

--- Subscribe to a newsletter written by one of many Wall Street professionals

Amylin Stock Is Catching A Bid

Amylin Pharmaceuticals (AMLN) has really been on a tear these past two trading days. As a long term holder of AMLN this is a pleasant development. However, I have to ask why the sudden jump in the stock over the past two trading sessions? There are several reasons for the sudden rise of AMLN of which any one or a combination of could be causing the rise. Here are some of those causal factors:

• The stock was simply too oversold and short interest climbed too high
• With all of the negative news about Zetia from Schering Plough (SGP) and Lipitor from Pfizer (PFE) and other statins perhaps someone finally woke up to the fact that diabetes treatment is all that much more important and the big cap pharmaceutical companies may be forced to buy AMLN
• The decline of the inhaled insulin product lines gives AMLN approved and commercially available products – Byetta and Symlin - more credibility and sales potential.

I continue to believe that AMLN Byetta LAR long acting formulation will be approved and once that occurs we will see a huge jump in analysts estimates and future sales. That is at least a year out but well worth the wait as Byetta and Symlin sales continue to grow.

At the time of this Blog entry Scott Rothbort, his family and or clients of LakeView Asset Management, LLC were long shares of AMLN --- although positions can change at any time.

MasterCard Deal With Ameriprise to Benefit MasterCard

Over the weekend MasterCard (MA) announced that it entered into an arrangement with Ameriprise Financial (AMP) whereby AMP would be issuing MasterCards and debit cards. This has to be a big letdown for AMP former parent American Express (AXP) and the soon to be public Visa. AMP has over 2 million clients all of which would be eligible for the new cards. As MA takes no credit risk, this would yield accretive processing fees for MA.

At the time of this Blog entry Scott Rothbort, his family and or clients of LakeView Asset Management, LLC were long shares of MA--- although positions can change at any time.

Dow Jones Blows Opportunity To Revitalize Its Industrial Index

When Dow Jones announced its decision to replace Altria (MO) and Honeywell (HON) with Bank of America (BAC) and Chevron (CVX) today, the brand now owned by News Corp (NWS) totally blew its opportunity to modernize the Dow Jones Industrial Average Index (DJIA/DIA/DDM). The price weighted DJIA is just plain out of touch with today's investors and professional money managers.

I will be on Fox Business Network's Happy Hour - also owned by NWS - tonight to discuss with my friend and the show's co-host Cody Willard what NWS needs to do to make the DJIA relevant once again. The show airs at 5PM EDT and is repeated at 11PM EDT.

At the time of this Blog entry Scott Rothbort, his family and or clients of LakeView Asset Management, LLC were long shares of BAC and DDM--- although positions can change at any time.

Observations Of Omniture

I was happy that my investment club members at Seton Hall were around to watch, listen and observe the Omniture (OMTR) earning release, conference call and after hours trading activity last evening. The stock got slammed after hours on a great quarter and guidance. I showed the kids how the stock was being walked down by 100 share sales constantly hitting the bid after hours. The stock dropped roughly 13% before the conference call began. This was a major gift to anyone who could trade after hours. More importantly, I pointed out that one could not read into that low volume after-hours blitzkrieg. During the conference call OMTR regained some ground as the after-hours manipulation ceased. It is now up 10% on the day in a real trading session. If you believe as I do in the long term growth of internet advertising then I suggest taking a look at OMTR. Oppenheimer recently put out a well written report on the stock.

At the time of this Blog entry Scott Rothbort, his family and or clients of LakeView Asset Management, LLC were long shares of OMTR--- although positions can change at any time.